We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
David Berntsen

David A. Berntsen OD, PhD

Associate Professor; Golden-Golden Professor of Optometry; Chair, Department of Clinical Sciences, College of Optometry, University of Houston, Houston, Texas

David A. Berntsen, OD, PhD, is an Associate Professor and the Golden-Golden Professor of Optometry at the University of Houston College of Optometry where he teaches in the graduate and professional programs. He is the Chair of the Department of Clinical Sciences and conducts research on myopia, contact lenses, and aberrations of the eye. He completed his Doctor of Optometry degree at the University of Houston and a Cornea and Contact Lens Advanced Practice Fellowship, MS, and PhD at The Ohio State University. He conducted the Study of Theories about Myopia Progression (STAMP), a two-year clinical trial evaluating theories of juvenile-onset myopia progression, and is the Principal Investigator of the University of Houston clinical site for the Bifocal Lenses In Nearsighted Kids (BLINK) Study and the BLINK2 Study, a multicenter study sponsored by the National Eye Institute evaluating contact lenses for myopia control. Dr. Berntsen serves on the American Academy of Optometry’s Scientific Program Committee.

Disclosures

Dr. Berntsen reports the following:
  • Bausch + Lomb (contact lens solution provided for an NIH/NEI-funded study)
  • Visioneering Technologies, Inc. (served on an Advisory Board)

Recent Contributions to PracticeUpdate:

  1. Benefits and Risks of Myopia Control